Work with the Yorkshire and Humber Academic Health Science Network (YHAHSN) continues to benefit patients.
One in three GP practices now have access to healthy.io, allowing patients living with diabetes and high blood pressure to test their urine for high levels of Albumin: Creatinine ratio (ACR) at home rather than travelling to see their GP. ACR testing can identify people at risk of kidney disease and currently uptake of these tests is low.
As a result of this work 24,000 patients have been identified as eligible and 10,000 patients tested. Of those people tested, c.35% were identified as having an abnormal/high abnormal reading and can now receive appropriate treatment. We are discussing the future commissioning of the service.
Another area of joint work is the NHSx and YHAHSN Yorkshire and Humber remote monitoring programme.
Eight sites in West Yorkshire are using remote monitoring technology to enable virtual wards for patients and for those in care homes. These allow patients to monitor their conditions at home and carers to monitor residents within the care home setting, with results going directly to their clinician who can then arrange appropriate contact and treatment.
Over a thousand Yorkshire and Humber patients have benefitted to date with more to come as the YHAHSN continues to roll out to additional sites, including nine in West Yorkshire.
PinPoint Data Science offers an new smart blood test that uses artificial-intelligence and will allow one in five patients to be ruled out of having one of the nine most common cancers, including breast, gynaecological, skin and head and neck cancers. This innovation, which is already active in West Yorkshire, helps NHS patients with a high risk of cancer get diagnosed and treated quicker, provide reassurance to patients that they are unlikely to have cancer and enable patients to be investigated for other conditions faster.
PinPoint was first introduced in Leeds following a collaboration with the Yorkshire & Humber AHSN, the Leeds Academic Health Partnership, the West Yorkshire Cancer Alliance and the University of Leeds.